1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Other Specified Pulmonary Tuberculosis: new trials by email Literature Review of Other Specified Pulmonary Tuberculosis trials Research Report on Other Specified Pulmonary Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PanACEA - STEP2C -01 BTZ-043, Rifampicin, Isoniazid - Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis | Phase 2 | Recruiting | Michael Hoelscher | 390 | 2023-04-14 | 2025-10-07 |
Tuberculosis (1) · Tuberculosis, Pulmonary (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
2-(2-methyl-1,4-dioxa-8-azaspiro(4.5)dec-8-yl)-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one (1) · Ethambutol (1) · Ethionamide (1) · GSK656 (1) · Isoniazid (1) · Moxifloxacin (1) · Pyrazinamide (1) · Rifampin (1) · delpazolid (1) · pretomanid (1)
Gabon (1) · Malawi (1) · Mozambique (1) · South Africa (1) · Tanzania (1) · Uganda (1)